Could S-1-based non-platinum doublet chemotherapy be a new option as a second-line treatment for advanced non-small cell lung cancer patients? A multicenter retrospective study.
Wang X, Wang T, Chu Y, Liu J, Yi C, Yu X, Wang Y, Zheng T, Cao F, Qu L, Yu B, Liu H, Ding F, Wang S, Wang X, Hao J, Wang X.
Wang X, et al. Among authors: wang y, wang t, wang s.
Front Oncol. 2023 Mar 16;13:1089234. doi: 10.3389/fonc.2023.1089234. eCollection 2023.
Front Oncol. 2023.
PMID: 37007066
Free PMC article.